Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Triptorelin

Decapeptyl, Trelstar, Gonapeptyl, Pamorelin

Quick Stats
Studies 178
Trials 100
Completed PHASE4 INTERVENTIONAL NCT02741154

Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

study the effect of aromataze inhibitor induction together with short stimulation protocol by gonadotrphin releasing hormon antagonist in cases that expected to be poor responder before ICSI

Detailed Description

This is a prospective randomized case control study will be conducted in Maternity hospital IVF unite Minia University after being approved by local ethical committee of obstetrics and gynecology department faculty of medicine, all study details will be explained to patients and informed consent will be obtained before inclusion in the study . enrolled patients will be randomized into two groups using simple randomization by sealed opaque envelops contain serial computer generated numbers Control group will receive HMG 300 IU daily start at first day of menses with follow up by trans vaginal ultrasound (TVUS ) when at least three follicles reach 14mm diameter GnRh antagonist given 0.1 ml continue follow up when at least three follicles reach 17mm in diameter ovum pickup will done under TVUS guide if less than three follicles cycle will be cancelled . Study group will receive same management plus letrozole 2.5mg daily start at the first day of menses for 5 days and continue with same protocol

Interventions

Name: induction with aromataze inhibitor
Type: DRUG
Description: letrozole 2.5mg once daily start in the first day of menses for 5days
Name: HMG
Type: DRUG
Description: HMG 300 IU injection once daily start at first day of menses with follow up by trans vaginal ultrasound (TVUS ) till at least three follicles reach 14 mm in diameter
Name: GnRh a
Type: DRUG
Description: antagonist given 0.1 ml injection once daily with continous follow up when at least three follicles reach 17mm in diameter HCG 10.000 IU injection and ovum pick up 24-36hours after injection
Name: HCG
Type: DRUG
Description: 10.000 IU HCG injection when at least three follicles reach 17mm in diameter

Primary Outcomes

Measure: Number of follicles per cycle that reach more than 17mm in diameter(quantity of ova)
TimeFrame: day of HCG injection
Description: measurement of the diameter of follicles by transvaginal ultrasoundand description of diameter in report
Measure: quality of ova
TimeFrame: day of ovum pick up
Description: After ova picking up examination of all ova under microscope and report how many ova reach metaphase II (quality) if more than 3 ova reach metaphase II considered satisfactory quality of ova in the current cycle

Trial Information

NCT ID

NCT02741154

Status

Completed

Study Type

INTERVENTIONAL

Phases

PHASE4

Sponsor

Minia University

Last Updated

December 15, 2025

Related Peptides